A convertible bond of Haemonetics Corp, a medical technology company providing blood- and plasma-collection systems, hospital devices and related software for transfusion and hemostasis management.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Howard Marks / Oaktree | 69 | New buy | 902,000 | $938,711 | 0.0% |
| Howard Marks / Oaktree | 69 | Added +63% | 15,030,000 | $14,917,275 | 0.2% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.